SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000921895-17-001246
Filing Date
2017-05-02
Accepted
2017-05-02 18:12:09
Documents
1
Period of Report
2017-04-28

Document Format Files

Seq Description Document Type Size
1 form407422010_05022017.html 4  
1 form407422010_05022017.xml 4 7970
  Complete submission text file 0000921895-17-001246.txt   9420
Mailing Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121 2062827100
CTI BIOPHARMA CORP (Issuer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE SANSOME STREET 30TH FLOOR SAN FRANCISCO CA 94104
Business Address
PERRY MATTHEW D (Reporting) CIK: 0001454337 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-28386 | Film No.: 17806554